STRUCTURAL AND MOLECULAR MODELING STUDIES OF QUINAZOLINONE ANTICONVULSANTS

被引:10
作者
DUKE, NEC
CODDING, PW
机构
[1] UNIV CALGARY,DEPT CHEM,CALGARY T2N 1N4,ALBERTA,CANADA
[2] UNIV CALGARY,DEPT PHARMACOL & THERAPEUT,CALGARY T2N 1N4,ALBERTA,CANADA
来源
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE | 1993年 / 49卷
关键词
D O I
10.1107/S0108768193000576
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Studies of derivatives of the anticonvulsant methaqualone led to the discovery that unsaturation in the 2-substituent produced active, but less toxic compounds; accordingly, 2-arylethanone derivatives have been developed. The crystal structures of five 2-arylethanone derivatives of methaqualone were determined to probe structure-activity relationships. Although these compounds display different activities, the solid-state and calculated structures are similar: each compound is observed as the enamine tautomer containing an intramolecular hydrogen bond between the ethanone and the amine N atom and the molecular conformations are the same. These studies conclude that recognition of the anticonvulsants arises from specific binding of an ortho substituent on the N(3) phenyl substituent, rather than from binding of a particular conformation or tautomeric form adopted by the compound containing an ortho substituent, and that such recognition is characteristic of a broad range of anticonvulsant drugs. Crystal data: (1), 2-[2-oxo-2-(4-pyfidyl)ethyl]3phenyl4(3H)quinazolinone, C2,H15N3O2, M(r) = 341.37, monoclinic, P2(1), a = 12.1646 (5), b = 5.5988 (2), c = 12.389 (2) angstrom, beta = 90.47 (1)degrees, V = 843.8 (1) angstrom3, Z = 2, D(x) = 1.35 g cm-3, lambda(Cu Kalpha) = 1.5418 angstrom, mu = 7.31 cm-1, T = 293 K, R = 0.039, 1764 unique reflections; (2), 3-(2-chlorophenyl)-2-[2-oxo-2-(4-pyridyl)ethyl-4(3H)-quinazolinone, C21H14ClN3O2, M(r) = 375.82, monoclinic, P2(1)/a, a = 10.9354 (6), b = 14.502 (1), c = 13.019 (1) angstrom, beta = 114.481 (4)degrees, V = 1879.0 (2) angstrom3, Z = 4, D(x) = 1.33 g cm-3, lambda(Cu Kalpha) = 1.5418 angstrom, mu = 19.87 cm-1, T = 293 K, R = 4.6%, 3550 unique reflections; (3), 3-(2-methylphenyl)-2-[2-oxo-2-(4-pyridyl)ethyl]-4(3H)-quinazolinone, C22H17N3O2, M(r) = 355.40, monoclinic, P2(1)/c, a = 5.618 (2), b = 30.329 (7), c = 10.456 (4) angstrom, beta = 98.21 (2)degrees, V = 1763.3 (9) angstrom3, Z = 4, D(x) = 1.34 g cm-3, lambda(Mo Kalpha) = 0.71069 angstrom, mu = 0.95 cm-1, T = 293K, R = 5.8%, 3075 unique reflections; (4), 3-(4-chlorophenyl)-2-[2-oxo-2-(4-pyridyl)ethyl]-4(3H)-quinazolinone, C21H14ClN3O2, M(r) = 375.82, orthorhombic, Pbca, a = 13.9347 (7), b = 9.6794 (6), c = 25.962 (1) angstrom, V = 3501.7 (3) angstrom3, Z = 8, D(x) = 1.43 g cm-3, lambda(Cu Kalpha) = 1.5418 angstrom, mu = 21.32 cm-1, T = 293K, R = 6.9%, 3385 unique reflections; (5), 3-(2-methylphenyl)-2-(2-oxophen-ethyl)-4(3H)-quinazolinone, C23H18N2O2, M(r) = 354.41, orthorhombic, Pbca, a = 10.2078( 4), b = 10.237 (1), c = 35.676 (3) angstrom, V = 3728.0 (5) angstrom3, Z = 8, D(x) = 1.26 g cm-3, lambda(Cu Kalpha) = 1.5418 angstrom, mu = 6.62 cm-1, T = 293K, R = 4.8%, 3532 unique reflections.
引用
收藏
页码:719 / 726
页数:8
相关论文
共 26 条
[1]   CONFORMATIONAL-ANALYSIS .130. MM2 - HYDROCARBON FORCE-FIELD UTILIZING V1 AND V2 TORSIONAL TERMS [J].
ALLINGER, NL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (25) :8127-8134
[2]  
BOLTZE K H, 1963, Arzneimittelforschung, V13, P688
[3]  
Camerman A., 1980, ANTIEPILEPTIC DRUGS, P223
[5]   CYHEPTAMIDE AND 3-HYDROXY-3-PHENACYLOXINDOLE - STRUCTURAL SIMILARITY TO DIPHENYLHYDANTOIN AS THE BASIS FOR ANTICONVULSANT ACTIVITY [J].
CODDING, PW ;
LEE, TA ;
RICHARDSON, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (05) :649-654
[6]  
CODDING PW, 1990, CRYSTALLOGRAPHIC MOD, P151
[7]   X-RAY SCATTERING FACTORS COMPUTED FROM NUMERICAL HARTREE-FOCK WAVE FUNCTIONS [J].
CROMER, DT ;
MANN, JB .
ACTA CRYSTALLOGRAPHICA SECTION A-CRYSTAL PHYSICS DIFFRACTION THEORETICAL AND GENERAL CRYSTALLOGRAPHY, 1968, A 24 :321-&
[8]   MOLECULAR MODELING AND CRYSTALLOGRAPHIC STUDIES OF 4-AMINO-N-PHENYLBENZAMIDE ANTICONVULSANTS [J].
DUKE, NEC ;
CODDING, PW .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) :1806-1812
[9]  
FRISCH MJ, 1990, GAUSSIAN90
[10]   APPLICATION OF PHASE RELATIONSHIPS TO COMPLEX STRUCTURES .3. OPTIMUM USE OF PHASE RELATIONSHIPS [J].
GERMAIN, G ;
MAIN, P ;
WOOLFSON, MM .
ACTA CRYSTALLOGRAPHICA SECTION A-CRYSTAL PHYSICS DIFFRACTION THEORETICAL AND GENERAL CRYSTALLOGRAPHY, 1971, A 27 (JUL1) :368-&